Allowance Plan Takes New Approach to Drug Benefits

There’s more to prescription drug benefit plans than copayments and deductibles. A new plan rolled out to Humana employees last year is based on drug allowances that help increase consumers’ awareness of their prescription drug options and costs.

The innovative benefit option — RxImpact (formerly RxAllowance) — proved popular enough to attract 18 percent of Humana employees when it was first offered last year. Although it is currently available only to Humana employees and their dependents, similar allowance plans may be added to the menu of health benefits at other employers as early as next year.

RxImpact places covered prescription drugs into four categories, or tiers (see chart), according to clinical use. Instead of owing a copayment, a patient who purchases or refills one of the covered drugs receives an allowance (dollar amount) that reduces the purchase cost by $5 to $40, depending on the drug’s tier. If the cost of the covered drug is less than its allowance, the patient pays nothing for the prescription and the excess allowance is rolled into a Personal Care Account.

Drug costs are based on Humana’s negotiated price, rather than full retail, and the consumer’s cost for each prescription purchase is capped. Plan participants also are protected by maximum annual out-of-pocket expense limits for drugs in three of the plan’s four tiers.

To check the tier level of drugs in RxImpact or the status of products in any other Humana prescription drug plan, go to www.humana.com, select the “Providers” area, choose the link to “Prescription Tools and Resources, and then select “Drug List Search.”

RxImpact Drug Tiers

Allowances are highest in Group A and decrease in groups B through D. Caps on the total cost-per-purchase apply to groups A through C only.

Group A: Includes brand and generic drugs that treat conditions including asthma, bacterial infections, juvenile diabetes, depression, HIV and prevention of pregnancy.

Group B: Includes brand and generic drugs to control illnesses and chronic conditions, such as cancer, heart disease and multiple sclerosis.

Group C: Includes brand and generic drugs that may reduce symptoms and improve day-to-day functioning for people with conditions such as allergies, arthritis and chronic pain.

Group D: Includes brand and generic drugs that may improve the well-being of people with conditions such as obesity, erectile dysfunction and tobacco addiction.

Back to top



Letter From Jack Lord
MYB Program Helps Consumers Rein in Drug Costs
HumanaAccess MasterCard Card Makes Getting
   Payments Easier
Allowance Plan Takes New Approach to Drug Benefits
Humana Releases New ID Cards
Personal Nurses Motivate Patients
Practice Innovation Pays Off

Ask an Expert